Kyle Moore
Frederick National Laboratory for Cancer Research
ORCID: 0000-0002-1280-241XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Elena M. Cornejo Castro, Charles Goodman, Nazzarena Labo, Isabella Liu, Nicholas C. Fisher +15 more
Papers
Driven by 6 papers — median percentile 58. Top paper: “Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma”.
Ramya Ramaswami, Irene Ekwede, Vanessa Eulo, Gaurav Goyal, Manoj Menon +22 more
Elena M. Cornejo Castro, Charles Goodman, Nazzarena Labo, Isabella Liu, Nicholas C. Fisher +15 more
Romin Roshan, Kyle Moore, Vickie Marshall, Wendell Miley, Nazzarena Labò +6 more
Ramya Ramaswami, Vickie Marshall, Elena M. Cornejo Castro, Nazzarena Labò, Wendell Miley +12 more
Kathryn Lurain, Lindsay Hill, Vickie Marshall, Elena M. Cornejo Castro, Nazzarena Labo +14 more
Sheena Knights, Elena M. Cornejo Castro, Nazzarena Labo, Isabella Liu, Wendell Miley +9 more